Freenome, Siemens Join Forces to Develop Blood Test for Breast Cancer
The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening, Fierce Biotech reports.
The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening, Fierce Biotech reports.
Rising procedure costs and evolving patient expectations are exposing weaknesses in plastic surgery payment workflows, pushing practices toward more modern, secure approaches.